Veterinary Immunodiagnostics Market Updates

Global Veterinary Immunodiagnostics Market size was valued at USD 2.7 billion in 2023 and is poised to grow from USD 2.92 billion in 2024 to USD 5.44 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

Pet adoption is on the rise right now because studies show that they help people's mental health. People are willing to spend a sizable amount of money to improve the health of their pets because they are worried about it. The participants have joined forces with a number of other businesses or 'IDEXX Laboratories, Inc. (USA) ', 'Zoetis Inc. (USA) ', 'Thermo Fisher Scientific Inc. (USA) ', 'bioMerieux SA (France) ', 'Heska Corporation (USA) ', 'NEOGEN Corporation (USA) ', 'Bio-Rad Laboratories, Inc. (USA) ', 'Virbac (France) ', 'FUJIFILM Holdings Corporation (Japan) ', 'Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China) ', 'INDICAL BIOSCIENCE GmbH (Germany) ', 'BioNote, Inc. (South Korea) ', 'Biogal Galed Labs (Israel) ', 'Agrolabo S.p.A. (Italy) ', 'IDvet (France) ', 'Randox Laboratories Ltd. (UK) ', 'BioChek (Netherlands) ', 'Biopanda Reagents (UK) ', 'URIT Medical Electronic Co., Ltd. (China) ', 'Bionote, Inc. (South Korea)'

At least 30 serious illnesses that affect people can be spread by animals. The majority of human infections are spread by livestock and companion animals (like dogs and cats) (such as pigs, chickens, cattle, goats, and camels). Major zoonotic illnesses that spread from animals to people include rabies, leptospirosis, cysticercosis, zoonotic tuberculosis, and gastrointestinal disease.

A number of zoonotic and vector-borne diseases are likely to become more common in the near future as a result of shifting social norms, habitat modification, the introduction of exotic vectors, and climate change. The need for quick and accurate diagnostic tools to stop these diseases will therefore drive the development of veterinary infectious disease diagnostics. According to the forecast, the development of companion animal medicine in developed nations will lead to further growth in the global market for veterinary infectious disease diagnostics. Furthermore, there is already a greater market demand for technologically advanced diagnostic techniques like RT PCR than there is for traditional diagnostic techniques.

Throughout the forecast period, North America is anticipated to continue to hold a commanding position in the veterinary immunodiagnostics market. The expansion of products on the market, the sizable stakes held by the major players in the area, and the rising accessibility and affordability of early detection all contribute to this dominance. The market in Asia Pacific is anticipated to expand at the fastest rate during the forecast period due to rising pet adoption rates, zoonotic disease occurrences, and a rise in the need for diagnostics for infectious diseases in livestock.